2022
DOI: 10.1002/bab.2322
|View full text |Cite
|
Sign up to set email alerts
|

Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results

Abstract: The pentose phosphate pathway (PPP), whose products are vital in biosynthetic events, is targeted in the treatment of many diseases such as cancer and malaria. The objective of this study was to identify new PPP inhibitors. The inhibition effects of methyl 4-amino benzoates on glucose 6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD) were analyzed through in vitro experiments and molecular docking studies were used to estimate inhibition mechanisms. IC 50 values of compounds were fou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 59 publications
0
2
0
Order By: Relevance
“…In the light of this information, the inhibition effects of methyl 4‐aminobenzoate derivatives on GST and GR activities, which are active in the GSH system, were investigated in our study. It was reported that methyl benzoate derivatives had high inhibitory effects on some metabolic enzymes such as human erythrocyte glucose 6‐phosphate dehydrogenase (G6PD), 6‐phosphogluconate dehydrogenase (6PGD), human serum paraoxonase 1 (PON1) α‐amylase, and α‐glucosidase in a micro molar range [39–41] …”
Section: Resultsmentioning
confidence: 99%
“…In the light of this information, the inhibition effects of methyl 4‐aminobenzoate derivatives on GST and GR activities, which are active in the GSH system, were investigated in our study. It was reported that methyl benzoate derivatives had high inhibitory effects on some metabolic enzymes such as human erythrocyte glucose 6‐phosphate dehydrogenase (G6PD), 6‐phosphogluconate dehydrogenase (6PGD), human serum paraoxonase 1 (PON1) α‐amylase, and α‐glucosidase in a micro molar range [39–41] …”
Section: Resultsmentioning
confidence: 99%
“…They determined that the cinnamic derivatives showed the most active properties. Kesebir [31] investigated methyl 4-aminobenzoates on 6-phosphogluconate dehydrogenase and glucose 6-phosphate dehydrogenase activity. Methyl 4-amino-2-nitrobenzoate displayed the best inhibitor property against glucose 6-phosphate dehydrogenase (K i : 117.8 � 15.7 μM) and methyl 4-amino-2-chlorobenzoate displayed the best inhibitor property against 6-phosphogluconate dehydrogenase enzyme activity (K i : 82.3 � 3.9 μM).…”
Section: Resultsmentioning
confidence: 99%
“…IC 50 was defined as the concentration of the compound causing 50 % inhibition, and it was calculated based on Activity (%)–[usnic and carnosic acid] plots for each compound [23,24] . The K i values and inhibition types were found using Lineweaver‐Burk plots [25,26] …”
Section: Methodsmentioning
confidence: 99%